Inhibitor Therapeutics Files 2024 Annual Report
Ticker: INTI · Form: 10-K · Filed: Mar 28, 2025 · CIK: 1042418
| Field | Detail |
|---|---|
| Company | Inhibitor Therapeutics, Inc. (INTI) |
| Form Type | 10-K |
| Filed Date | Mar 28, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceutical
TL;DR
INTI filed its 2024 10-K. All systems go.
AI Summary
Inhibitor Therapeutics, Inc. filed its 10-K for the fiscal year ending December 31, 2024. The company, formerly known as HedgePath Pharmaceuticals, Inc. and COMMONWEALTH BIOTECHNOLOGIES INC, is based in Tampa, Florida. The filing covers financial information and business operations for the period.
Why It Matters
This 10-K filing provides investors and stakeholders with a comprehensive overview of Inhibitor Therapeutics' financial health and operational status for the fiscal year 2024.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Inhibitor Therapeutics faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period for the 10-K)
- 2025-03-28 — Filing Date (Date the 10-K was submitted to the SEC)
Key Players & Entities
- Inhibitor Therapeutics, Inc. (company) — Filer
- HedgePath Pharmaceuticals, Inc. (company) — Former company name
- COMMONWEALTH BIOTECHNOLOGIES INC (company) — Former company name
- Tampa, FL (location) — Business and mailing address
- 2024-12-31 (date) — Fiscal year end
- 2025-03-28 (date) — Filing date
FAQ
What is the primary business of Inhibitor Therapeutics, Inc.?
Inhibitor Therapeutics, Inc. is classified under Pharmaceutical Preparations (SIC code 2834).
When did the company change its name from HedgePath Pharmaceuticals, Inc.?
The company's name change from HedgePath Pharmaceuticals, Inc. occurred on August 16, 2013.
What is the SEC file number for Inhibitor Therapeutics, Inc.?
The SEC file number for Inhibitor Therapeutics, Inc. is 001-13467.
Where is Inhibitor Therapeutics, Inc. located?
The company's business and mailing address is 4830 W. KENNEDY BLVD., SUITE 600, TAMPA, FL 33609.
What fiscal year does this 10-K filing cover?
This 10-K filing covers the fiscal year ending December 31, 2024.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 28, 2025 regarding Inhibitor Therapeutics, Inc. (INTI).